Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-20 Purchase |
2021-12-21 4:05 pm |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
2,000 | $4.48 | $8,960 | 9,000 (Direct) |
View |
2021-08-17 Purchase |
2021-08-19 4:05 pm |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
4,000 | $6.21 | $24,840 | 7,000 (Direct) |
View |
2021-06-09 Purchase |
2021-06-10 5:25 pm |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
3,000 | $8.01 | $24,030 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
666,500 | $0 | 666,500 (Direct) |
View |
2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
1,015,743 | $0 | 1,015,743 (Direct) |
View |
2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
517,454 | $0 | 517,454 (Direct) |
View |
2023-05-01 Option Award |
2023-05-02 6:49 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
383,299 | $0 | 383,299 (Direct) |
View |
2023-02-01 Option Award |
2023-02-02 5:56 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
453,600 | $0 | 453,600 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:38 pm |
N/A 2032-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer |
108,000 | $0 | 108,000 (Direct) |
View |
2020-09-11 Option Award |
2020-09-15 8:12 pm |
N/A 2020-09-11 |
Novus Therapeutics Inc. | NVUS | Gros David-Alexandre C Chief Executive Officer |
18,278 | $0 | 18,278 (Direct) |
View |